CD8A and COVID-19: After establishing that the skewed TCR repertoire observed in the activated CD8+ T-cell subset (compared to the nonactivated subset) is linked with a significant enrichment of SARS-CoV-2–associated TCRs in COVID-19 patients, we then validated that enumeration of SARS-CoV-2–associated TCRs in this subset is a diagnostic marker for COVID-19.